30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs

por Des Jarlais, D. C., Pinkerton, S., Hagan, H., Guardino, V., Feelemyer, J., Cooper, H., Hatzatkis, A., Uuskula, A.
Publicado 2013

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for...

por Des Jarlais, D. C., Cooper, H. L. F., Arasteh, K., Feelemyer, J., McKnight, C., Ross, Z.
Publicado 2018

Geographic distribution of risk (“Hotspots”) for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history

por Des Jarlais, D.C., McKnight, C., Arasteh, K., Feelemyer, J., Ross, Zev, Cooper, H. L. F.
Publicado 2019

Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North Amer...

por Wiessing, Lucas, Sypsa, V., Abagiu, A. O., Arble, A., Berndt, N., Bosch, A., Buskin, S., Chemtob, D., Combs, B., Conyngham, C., Feelemyer, J., Fitzgerald, M., Goldberg, D., Hatzakis, A., Patrascu, R. E., Keenan, E., Khan, I., Konrad, S., Leahy, J., McAuley, A., Menza, T., Merrick, S., Metcalfe, R., Rademaker, T., Revivo, S., Rosca, P., Seguin-Devaux, C., Skinner, S., Smith, C., Tinsley, J., Wilberg, M., Des Jarlais, D.
Publicado 2022